$ICUI
ICU Medical Inc

2012 Q2 Form 10-Q Financial Statement

#000088398412000080 Filed on July 20, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2011 Q2
Revenue $77.28M $77.80M
YoY Change -0.66% 13.36%
Cost Of Revenue $38.20M $41.60M
YoY Change -8.16% 13.23%
Gross Profit $39.08M $36.20M
YoY Change 7.96% 13.52%
Gross Profit Margin 50.57% 46.53%
Selling, General & Admin $22.81M $19.73M
YoY Change 15.59% 1.85%
% of Gross Profit 58.35% 54.5%
Research & Development $2.729M $2.491M
YoY Change 9.55% 161.66%
% of Gross Profit 6.98% 6.88%
Depreciation & Amortization $4.700M $4.600M
YoY Change 2.17% 15.0%
% of Gross Profit 12.03% 12.71%
Operating Expenses $25.54M $22.22M
YoY Change 14.91% 9.33%
Operating Profit $13.55M $13.98M
YoY Change -3.1% 18.44%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $145.0K $431.0K
YoY Change -66.36% 584.13%
Pretax Income $13.69M $14.41M
YoY Change -4.99% 21.45%
Income Tax $4.543M $4.918M
% Of Pretax Income 33.18% 34.13%
Net Earnings $9.149M $9.493M
YoY Change -3.62% 25.47%
Net Earnings / Revenue 11.84% 12.2%
Basic Earnings Per Share $0.65 $0.69
Diluted Earnings Per Share $0.63 $0.67
COMMON SHARES
Basic Shares Outstanding 14.18M shares 13.85M shares
Diluted Shares Outstanding 14.62M shares 14.26M shares

Balance Sheet

Concept 2012 Q2 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $193.5M $120.8M
YoY Change 60.18% 45.37%
Cash & Equivalents $121.6M $87.37M
Short-Term Investments $71.90M $33.40M
Other Short-Term Assets $10.30M $12.40M
YoY Change -16.94% 16.98%
Inventory $36.54M $49.37M
Prepaid Expenses
Receivables $43.84M $51.79M
Other Receivables $9.300M $4.500M
Total Short-Term Assets $293.4M $238.9M
YoY Change 22.84% 29.61%
LONG-TERM ASSETS
Property, Plant & Equipment $82.18M $87.56M
YoY Change -6.15% 8.77%
Goodwill $1.478M $1.478M
YoY Change 0.0%
Intangibles $10.75M $13.78M
YoY Change -22.0%
Long-Term Investments
YoY Change
Other Assets $4.800M $4.600M
YoY Change 4.35% 24.32%
Total Long-Term Assets $99.15M $107.5M
YoY Change -7.73% 4.94%
TOTAL ASSETS
Total Short-Term Assets $293.4M $238.9M
Total Long-Term Assets $99.15M $107.5M
Total Assets $392.6M $346.3M
YoY Change 13.36% 20.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.28M $12.31M
YoY Change -0.25% -29.67%
Accrued Expenses $17.55M $14.47M
YoY Change 21.26% 5.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $29.83M $26.78M
YoY Change 11.37% -14.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.100M $4.500M
YoY Change -8.89% -6.25%
Total Long-Term Liabilities $4.100M $4.500M
YoY Change -8.89% -6.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.83M $26.78M
Total Long-Term Liabilities $4.100M $4.500M
Total Liabilities $41.10M $39.20M
YoY Change 4.85% -6.22%
SHAREHOLDERS EQUITY
Retained Earnings $317.6M $276.4M
YoY Change 14.93%
Common Stock $61.69M $57.86M
YoY Change 6.61%
Preferred Stock
YoY Change
Treasury Stock (at cost) $22.54M $31.13M
YoY Change -27.59%
Treasury Stock Shares 892.0K shares
Shareholders Equity $351.5M $307.1M
YoY Change
Total Liabilities & Shareholders Equity $392.6M $346.3M
YoY Change 13.36% 20.8%

Cashflow Statement

Concept 2012 Q2 2011 Q2
OPERATING ACTIVITIES
Net Income $9.149M $9.493M
YoY Change -3.62% 25.47%
Depreciation, Depletion And Amortization $4.700M $4.600M
YoY Change 2.17% 15.0%
Cash From Operating Activities $13.20M $10.30M
YoY Change 28.16% 41.1%
INVESTING ACTIVITIES
Capital Expenditures -$4.900M -$4.900M
YoY Change 0.0% 444.44%
Acquisitions
YoY Change
Other Investing Activities -$11.90M $4.600M
YoY Change -358.7% -71.6%
Cash From Investing Activities -$16.80M -$100.0K
YoY Change 16700.0% -100.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.800M 6.000M
YoY Change -20.0% -233.33%
NET CHANGE
Cash From Operating Activities 13.20M 10.30M
Cash From Investing Activities -16.80M -100.0K
Cash From Financing Activities 4.800M 6.000M
Net Change In Cash 1.200M 16.20M
YoY Change -92.59% -10.5%
FREE CASH FLOW
Cash From Operating Activities $13.20M $10.30M
Capital Expenditures -$4.900M -$4.900M
Free Cash Flow $18.10M $15.20M
YoY Change 19.08% 85.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12277000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13251000 USD
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43839000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43571000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16059000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
399000 USD
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17548000 USD
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
99902000 USD
CY2012Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
107384000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3234000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5251000 USD
CY2012Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
60200000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
56796000 USD
CY2011Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
145000 shares
CY2011Q4 us-gaap Assets
Assets
361112000 USD
CY2012Q2 us-gaap Assets
Assets
392591000 USD
CY2012Q2 us-gaap Assets Current
AssetsCurrent
293438000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
260408000 USD
CY2011Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
60395000 USD
CY2012Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
71931000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
262000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
77000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99590000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121560000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87368000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78850000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8518000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
21970000 USD
CY2011Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
159985000 USD
CY2012Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
193491000 USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
1486000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
1486000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14733000 USD
CY2011Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10700000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5045000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
22642000 USD
CY2011Q4 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2012Q2 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
78440000 USD
CY2011Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
41595000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
78745000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
38199000 USD
CY2012Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4467000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4081000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4759000 USD
CY2012Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4751000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7144000 USD
CY2012Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7160000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9052000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9533000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Pronouncements:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.28
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.24
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-938000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1167000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.34
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.35
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2758000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2717000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
56000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-27000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
2500000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
1478000 USD
CY2012Q2 us-gaap Goodwill
Goodwill
1478000 USD
us-gaap Gross Profit
GrossProfit
74047000 USD
us-gaap Gross Profit
GrossProfit
70827000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
39082000 USD
CY2011Q2 us-gaap Gross Profit
GrossProfit
36201000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14411000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13692000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
25209000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27025000 USD
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4918000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4543000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9459000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8459000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-608000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1286000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
850000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3908000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1582000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-599000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-254000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4025000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3707000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-821000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1373000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
394000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
417000 shares
CY2011Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
405000 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
441000 shares
CY2012Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10749000 USD
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11419000 USD
CY2011Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12295000 USD
CY2012Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12358000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
40423000 USD
CY2012Q2 us-gaap Inventory Net
InventoryNet
36535000 USD
CY2012Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
20651000 USD
CY2011Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
25227000 USD
CY2012Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
3526000 USD
CY2011Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2901000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
985000 USD
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
392591000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
361112000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
29310000 USD
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
29825000 USD
CY2011Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4081000 USD
CY2012Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4081000 USD
us-gaap Litigation Settlement Gross
LitigationSettlementGross
2500000 USD
CY2012Q2 us-gaap Litigation Settlement Gross
LitigationSettlementGross
0 USD
CY2011Q2 us-gaap Litigation Settlement Gross
LitigationSettlementGross
0 USD
us-gaap Litigation Settlement Gross
LitigationSettlementGross
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13172000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8198000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21736000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26310000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31472000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25463000 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
145000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
834000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
280000 USD
CY2011Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
431000 USD
us-gaap Operating Expenses
OperatingExpenses
44636000 USD
us-gaap Operating Expenses
OperatingExpenses
49118000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
25535000 USD
CY2011Q2 us-gaap Operating Expenses
OperatingExpenses
22221000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
26191000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
24929000 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13980000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13547000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4104000 USD
CY2011Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1207000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2017000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5076000 USD
CY2011Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
135000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
268000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
270000 USD
CY2012Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
142000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
620000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
53966000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
32236000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8222000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9755000 USD
CY2012Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5849000 USD
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6759000 USD
CY2012Q2 us-gaap Prepaid Taxes
PrepaidTaxes
9257000 USD
CY2011Q4 us-gaap Prepaid Taxes
PrepaidTaxes
5589000 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
2781000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
41062000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
12900000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9333000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4572000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
909000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1081000 USD
us-gaap Profit Loss
ProfitLoss
16750000 USD
CY2012Q2 us-gaap Profit Loss
ProfitLoss
9149000 USD
us-gaap Profit Loss
ProfitLoss
17566000 USD
CY2011Q2 us-gaap Profit Loss
ProfitLoss
9493000 USD
CY2012Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
189559000 USD
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
182950000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
83048000 USD
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82175000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
437000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-152000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4543000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5422000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2729000 USD
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2491000 USD
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
317627000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
300877000 USD
us-gaap Revenues
Revenues
152792000 USD
CY2011Q2 us-gaap Revenues
Revenues
77796000 USD
us-gaap Revenues
Revenues
149267000 USD
CY2012Q2 us-gaap Revenues
Revenues
77281000 USD
CY2011Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
77661000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
148999000 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
77139000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
152522000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42593000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22806000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
43696000 USD
CY2011Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19730000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3042000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1979000 USD
CY2012Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
351525000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
320577000 USD
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
35348000 USD
CY2012Q2 us-gaap Treasury Stock Value
TreasuryStockValue
22537000 USD
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14620000 shares
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14257000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14166000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14484000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14179000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14067000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13772000 shares
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13852000 shares
CY2012Q2 icui Debt Securities Maturity Date Range High
DebtSecuritiesMaturityDateRangeHigh
2043
CY2012Q2 icui Debt Securities Maturity Date Range Low
DebtSecuritiesMaturityDateRangeLow
2012
icui Increase Decrease In Prepaid And Deferred Income Taxes
IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes
-2857000 USD
icui Increase Decrease In Prepaid And Deferred Income Taxes
IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes
-3612000 USD
icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
247000 USD
CY2012Q2 dei Amendment Flag
AmendmentFlag
false
CY2012Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2012Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q2 dei Document Period End Date
DocumentPeriodEndDate
2012-06-30
CY2012Q2 dei Document Type
DocumentType
10-Q
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14268055 shares
CY2012Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2012Q2 dei Entity Registrant Name
EntityRegistrantName
ICU MEDICAL INC/DE
CY2012Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000883984

Files In Submission

Name View Source Status
0000883984-12-000080-index-headers.html Edgar Link pending
0000883984-12-000080-index.html Edgar Link pending
0000883984-12-000080.txt Edgar Link pending
0000883984-12-000080-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
icui-20120630.xml Edgar Link completed
icui-20120630.xsd Edgar Link pending
icui-20120630_cal.xml Edgar Link unprocessable
icui-20120630_def.xml Edgar Link unprocessable
icui-20120630_lab.xml Edgar Link unprocessable
icui-20120630_pre.xml Edgar Link unprocessable
icui-ex311_20120630x10q.htm Edgar Link pending
icui-ex312_20120630x10xq.htm Edgar Link pending
icui-ex321_20120630x10q.htm Edgar Link pending
icui0630201210-q.htm Edgar Link pending
icumedicalincamended2011st.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending